about
Non-tumor cell IDO1 predominantly contributes to enzyme activity and response to CTLA-4/PD-L1 inhibition in mouse glioblastoma.The Kynurenine/Tryptophan Ratio and Glioblastoma Patients Treated with Hsppc-96 Vaccine.Profiling dendritic cell subsets in head and neck squamous cell tonsillar cancer and benign tonsils.Trial watch: DNA-based vaccines for oncological indications
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Improving vaccine efficacy against malignant glioma
@en
type
label
Improving vaccine efficacy against malignant glioma
@en
prefLabel
Improving vaccine efficacy against malignant glioma
@en
P2093
P2860
P1433
P1476
Improving vaccine efficacy against malignant glioma
@en
P2093
Alicia Lenzen
C David James
David C Binder
Erik Ladomersky
Galina Gritsina
Jason Fangusaro
Jeffrey J Raizer
Kristen L Lauing
Lijie Zhai
Matthew Genet
P2860
P304
P356
10.1080/2162402X.2016.1196311
P577
2016-06-10T00:00:00Z